Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure
- 18 March 2011
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 331 (6023), 1439-1443
- https://doi.org/10.1126/science.1200113
Abstract
Decreased cardiac contractility is a central feature of systolic heart failure. Existing drugs increase cardiac contractility indirectly through signaling cascades but are limited by their mechanism-related adverse effects. To avoid these limitations, we previously developed omecamtiv mecarbil, a small-molecule, direct activator of cardiac myosin. Here, we show that it binds to the myosin catalytic domain and operates by an allosteric mechanism to increase the transition rate of myosin into the strongly actin-bound force-generating state. Paradoxically, it inhibits adenosine 5′-triphosphate turnover in the absence of actin, which suggests that it stabilizes an actin-bound conformation of myosin. In animal models, omecamtiv mecarbil increases cardiac function by increasing the duration of ejection without changing the rates of contraction. Cardiac myosin activation may provide a new therapeutic approach for systolic heart failure.Funding Information
- National Institutes of Health (1-R43-HL-66647-1)
This publication has 24 references indexed in Scilit:
- Improvement of Cardiac Function by a Cardiac Myosin Activator in Conscious Dogs With Systolic Heart FailureCirculation: Heart Failure, 2010
- Systolic Heart FailureThe New England Journal of Medicine, 2010
- Effects of Cardiac Myosin Isoform Variation on Myofilament Function and Crossbridge Kinetics in Transgenic RabbitsCirculation: Heart Failure, 2009
- Chapter 6 Kinetic and Equilibrium Analysis of the Myosin ATPaseMethods in Enzymology, 2009
- Heart Failure Incidence and Survival (from the Atherosclerosis Risk in Communities Study)The American Journal of Cardiology, 2008
- Mechanisms and Use of Calcium-Sensitizing Agents in the Failing HeartCirculation, 2006
- Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)American Heart Journal, 2005
- Direct, Real-Time Measurement of Rapid Inorganic Phosphate Release Using a Novel Fluorescent Probe and Its Application to Actomyosin Subfragment 1 ATPaseBiochemistry, 1994
- Alterations in left ventricular diastolic function in conscious dogs with pacing-induced heart failure.JCI Insight, 1992
- Mechanism of adenosine triphosphate hydrolysis by actomyosinBiochemistry, 1971